Financials Archives - Page 38 of 40

DRREDDY – Q3 FY26 Earnings Call – 21-Jan-26

Dr.Reddy’s topline growth hinges on Semaglutide/Abatacept execution and EM resilience, while margins face structural pressure from Lenalidomide exit, FX, and biosimilar delays; base case implies 6–8% revenue growth with 24–26% EBITDA, but bear-case risks skew asymmetric.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Semaglutide launches in Canada (May 2026, $50/unit) and India (March 2026, $30/unit), contributing $150–200M revenue. Abatacept EU approval (July 2027) and US Rituximab re-inspection (H1CY27) proceed as guided. EM grows 20% YoY; India sustains 15%+ organic growth. EBITDA margins recover to 24–26% on cost controls. Implication: 6–8% revenue growth; 10–12% EPS growth.

AXISBANK – Q3 FY26 Earnings Call – 26-Jan-26

Axis Bank’s base case sees NIM stabilizing near 3.6–3.7% with ROE at 14–15%, while bear case risks compression to 3.4–3.5% and ROE 12–13%. Bull case offers upside with NIM above 3.8% and ROE 16%+, hinging on deposit growth and digital monetization.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Triggers: Deposit growth converges in 15–18 months, retail disbursements sustain +20% YoY, no further rate cuts.
Outcome: NIM stabilizes at 3.6–3.7% (Q4 dip offset by 2027 rebalancing), credit costs 60–70 bps, ROE 14–15%. CET-1 remains >14% (AT1 issuance likely). Action: Model 58–60% retail mix by FY28, watch Neo platform monetization.

TATACOMM – Q3 FY26 Earnings Call – 21-Jan-26

TATACOMM’s topline: 8–12% CAGR feasible if digital (15% YoY) offsets core cyclicality (3–5% YoY); Bottomline: EBITDA margin expansion to 22–25% hinges on AI/SaaS execution and cost discipline; Margins: Structural upside in cloud/security (18.9% YoY) and CIS (post-contract exits), but media/MOVE drag persists.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: (1) Commotion pilots convert to revenue (10% digital growth by FY27); (2) Core connectivity stabilizes (3–4% YoY growth).
Outcome: Digital breakeven by FY27; EBITDA margins expand to 22% by FY28. Revenue CAGR of 8–10%, driven by cloud/security (18.9% YoY) and next-gen connectivity (17% YoY). FCF: INR 1,200–1,500 Cr annualized post-FY26.

PERSISTENT – Q3 FY26 Earnings Call – 20-Jan-26

PERSISTENT sustains 15–20% growth with BFSI, healthcare, and AI as drivers. Margins stay range-bound at 14–16% amid structural pressures, while AI monetization and disciplined cash flow management shape profitability.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Steady macro (NA/EU tech spend +3–5%) + AI tool adoption scales linearly (50–75 bps annual margin tailwind).

Revenue grows 15–17% YoY, driven by BFSI/Healthcare modernization and hi-tech product development. Top 100 clients expand at 18–20% YoY.
EBIT margin stabilizes at 14–15%, with labour code impact offset by AI productivity gains. Operating cash flow recovers to 95–100% of PAT as DSO normalizes to 55 days.
EPS rises to ₹30–32, supporting dividend hikes (₹24–26/share) and selective M&A for AI/data capabilities.

DLF – Q3 FY26 Earnings Call – 19-Jan-26

DLF’s topline resilient (FY26 guidance intact; FY27 pipeline robust), margins protected by pricing power and cost discipline, but execution risks (GRAP, RERA, contractors) cap near-term upside; FCF growth hinges on RERA unlock and land monetization timing.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: GRAP delays contained (45 days), NRI demand stable, RERA unlock begins FY27.
Outcome: FY26 sales at guidance mid-point (Rs. 21,000 crore); FY27 launches on track (Arbour 2, Westpark, Panchkula). Rental income grows 17% YoY (Rs. 7,400 crore). Dividend payout ratio 75–80% sustained. Stock trades at 1.2–1.3x P/B.

TATACAP – Q3 FY26 Earnings Call – 19-Jan-26

TATACAP’s topline growth (18–20% AUM) and margin stability (NIM 6.6%) are credible, but bottomline upside (PAT growth) hinges on credit cost trajectory (1.0–1.2%) and Motor Finance execution, with structural tech efficiency offsetting cyclical macro risks.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Unsecured retail slippages stabilize; Motor Finance AUM grows 5–7% YoY; housing margins hold at 2.4% ROA.
Outcome: Credit costs trend to 1.0–1.1%; consolidated ROA at 2.0–2.2%. AUM growth at 18–20%. NIM expansion of 5–10bps on funding cost tailwinds.

ICICIBANK – Q3 FY26 Earnings Call – 17-Jan-26

ICICIBANK’s outlook splits into Base Case with NIM steady at 3.0–4.3% and ROE 15–21%; Bear Case with margin compression to 2.8–4.0% and ROE 13–14%; Bull Case with NIM expansion above 3.1–4.4% and ROE 17–22%.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: (1) PSL portfolio conformity achieved by H1-2027, limiting provisions to ₹12.83B; (2) Retail deposit repricing offsets 50% of repo cut impacts. Outcome: PBT grows 3–5% YoY (adjusted for provisions), with NIM stable at 4.20–4.30%. Loan growth sustains at 11–12% YoY, led by business banking. RoE holds at 15–16%. Signal: Credit card/personal loan growth recovers to 8–10% YoY by H2-2027.

NETWEB – Q3 FY26 Earnings Call – 19-Jan-26

NETWEB’s topline likely to sustain 30–40% CAGR on AI/HPC tailwinds, but lumpiness in strategic orders and ASIC disruption risks could compress margins (9–12% PAT range) and cash flow visibility; modeling should prioritize annualized trends over quarterly volatility.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: (1) AI mission executes as planned (₹17B strategic orders over 3 years); (2) ASICs remain niche (<10% of AI market).
Outcome: 30–40% organic CAGR sustained; AI systems contribute 50–60% of revenue. Margins stabilize at 9–10% PAT (13–14% ex-strategic). PLI approvals add 100–150 bps to EBITDA. Implication: ₹20B+ topline by FY28; 15–20% EPS CAGR.

PNB – Q3 FY26 Earnings Call – 19-Jan-26

PNB’s topline resilience (11–12% credit growth) and margin stabilization by Q2FY27 hinge on deposit repricing and ECL management; bottomline upside (5–15% EPS growth) depends on fee income scalability and recovery execution, with structural risks skewed to ECL and rate sensitivity.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Trigger: Stable rates + ECL provisions ≤INR500Cr/quarter.
Outcome: NIM stabilizes at 2.55–2.60% by Q2FY27; credit costs at 15–20 bps; EPS grows 5–7% on fee income diversification. GNPA below 3%, NNPA 0.30–0.35%.

RELIANCE – Q3 FY26 Earnings Presentation – 16-Jan-26

Market Scenarios at a Glance — Base case: Brent $60–70/bbl, 5G ARPU flat, FMCG +15–20%, EBITDA +5–7%, margins stable. Bear case: Brent <$50, ARPU drops, margins shrink, debt rises. Bull case: Brent >$75, ARPU +10%, EBITDA +20%+, margins peak, debt falls. New Energy hinges on oil trends.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Brent $60–70/bbl, 5G ARPU flat, FMCG revenue grows 15–20%.
Outcome: EBITDA growth 5–7%, Jio margins 51–52%, Retail margins 7.5–8%. Net debt/EBITDA stable at 0.55x; EPS growth 5–10%. New Energy projects delayed but on track.